Invasive fungal rhinosinusitis: a 15-year experience with 29 patients

Marcus M Monroe1, Max McLean, Nathan Sautter

  • 1Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon 97239-3098, USA.

The Laryngoscope
|February 19, 2013
PubMed
Abstract

Insights

Acute invasive fungal rhinosinusitis (AIFR) has a low survival rate, with intracranial involvement and cranial neuropathy being poor prognostic indicators. Survivors face significant long-term sinonasal complications.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Mycology

Background:

  • Acute invasive fungal rhinosinusitis (AIFR) is a severe infection often seen in immunocompromised patients.
  • Early diagnosis and management are crucial for patient outcomes.

Purpose of the Study:

  • To document a 15-year experience with 29 cases of AIFR.
  • To identify factors predicting disease clearance and overall survival in AIFR patients.

Main Methods:

  • A retrospective case series design was employed.
  • Patient data were collected via chart review of billing records from 1995 to 2010.
  • Demographics, disease characteristics, treatment, and outcomes were analyzed.

Main Results:

  • Twenty-nine AIFR cases were identified, with immunosuppression from hematologic malignancy and diabetes being common.
  • Mucor and Aspergillus were the most frequent fungal pathogens.
  • Disease-specific survival was 57%, with intracranial and ethmoid sinus involvement linked to mortality. Overall survival at 6 months was 18%.

Conclusions:

  • AIFR is associated with low disease-specific and overall survival rates.
  • Intracranial involvement and cranial neuropathy at presentation are poor prognostic indicators.
  • Long-term survivors require close follow-up due to the risk of sinonasal complications.